Filing Details
- Accession Number:
- 0001384101-19-000144
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-02 16:13:33
- Reporting Period:
- 2019-11-27
- Accepted Time:
- 2019-12-02 16:13:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769333 | C Giulia Kennedy | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Scientific & Med Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-27 | 3,697 | $14.34 | 51,146 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-27 | 3,697 | $29.36 | 47,449 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-27 | 3,697 | $0.00 | 3,697 | $14.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 46,303 | 2024-02-18 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019.
- Represents weighted average sales price. Sale prices for the transactions range from $29.34 to $29.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option is fully vested.
Billionaire Hedge Funds
